Dr. Milen Vrabevski with award "Father of the Year 2016"

On February 22, 2017 in the Sofia gallery "Nirvana" a special…
Dr. Milen Vrabevski

Address by Dr. Milen Vrabevski

Dear Colleagues, Through the daily rush, focused on tasks and…

Our successful development is best represented by the following

  • Coverage of 21 countries
  • 20 years experience
  • 623 completed Clinical Trials
  • 363 Quality of Life projects
  • 10 000 Study Investigators
  • 841 Audits/ Inspections/ Co-monitoring visits
  • 360 Certificates of quality/ Attendance/ Recognition and Training
  • FDA inspected sites, NAI Letters issued
  • FDA Pre-IND Meetings
  • EU RA Scientific Advice Meetings


  • Certificate of Recognition by USA NIH (2002)
  • FDA inspected Sites
  • EMA inspected Sites
  • PMDA inspected Sites
  • FDA pre-IND Meetings
  • EU Scientific Advice Meetings on drug development programs with EU Competent Authorities
  • 24-bed (incl. 6 intensive care) Early Phase Clinical Research Center (since 2005), Certified by the Ministry of Research and Science of France
  • ISO 9001:2008 Certified and Re-certified (since 2004)
  • CDISC Partner
  • DIA Partner
  • Academia Partner
  • PSCI Principles Compliant
  • HORIZON 2020 Beneficiary
  • Milen Vrabevski, MD (Owner/CEO) – Member of Clinton Global Initiative (2012)
  • Milen Vrabevski, MD (Owner/CEO) – European Citizens’ Prize laureate (2013)
  • PYTHAGORAS Reward Laureate, granted for contribution to science by the Ministry of Education & Science (2016)

Comac Medical reach


Bulgaria (Sofia HQ) Germany Croatia Latvia Lithuania Estonia Georgia
Macedonia Romania Serbia Moldova Montenegro Slovenia Poland
Hungary Albania Kosovo Cyprus Greece Sweden Bosnia and Herzegovina
© Copyright - Comac Medical Ltd.